ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,599, issued on Nov. 4, was assigned to CTI Vascular AG (Neuhausen, Switzerland).
"Bioactivatable devices and related methods" was invented by Ulf Fritz (Bargen, Switzerland) and Marc Gianotti (Wiesendangen, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is related to inorganic, biocompatible material compositions for bioactivatable devices, devices, and products comprising transition metal chalcogenides, such as molybdenum sulfides, that can be converted in vivo from a non-bioactive state to a bioactive state upon exposure to physiological conditions, wherein the bioactivated transition metal chalcogenide derivative...